[1]刘继洪,潘月龙. 紫杉醇和卡铂联合化疗方案治疗老年晚期非小细胞肺癌临床分析[J]. 中国药物与临床,2009, 9(2): 152-153. [2] Singla AK,Garg A,Aggarwal D. Paclitaxel and its formulations [J]. Int J Pharm,2002,235 (122):179-181 [3]陈 鹏,李丽庆,李淑芬,等. 紫杉醇脂质体与紫杉醇在肿瘤患者的临床III期试验[J]. 中国肿瘤临床,2003,30(2): 141-143. [4]杨爱珍,李 军,徐海军,等. 紫杉醇脂质体的体内外抗肿瘤作用研究[J]. 中国肿瘤,2006,15(12):862-864. [5]周 蔚,周彩存,孟淑燕,等. 靶向肺癌的紫杉醇长循环脂质体抑瘤作用研究[J]. 肿瘤,2011,31(3):203-209. [6]张敬伟,任中海,张成辉,等. 紫杉醇脂质体单药治疗老年晚期非小细胞肺癌的临床观察[J]. 中华肿瘤防治杂志,2009,16(12):943-944. [7]江 澜. 紫杉醇酯质体与传统紫杉醇治疗晚期非小细胞肺癌的疗效对比[J]. 江苏医药,2010,36(1):108-109. [8] Schmit T,Sody M,Strieth S,et al. Neovascular targeting therapy paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy[J]. Clin Cancer Res,2003,9 (6): 2335-2341. [9]陈 强,张其忠,刘 健,等. 紫杉醇脂质体与传统紫杉醇治疗乳腺癌和非小细胞肺癌的随机对照研究[J]. 中华肿瘤杂志,2003,25(2):190-192. [10] Cabanes A,Briggs KE,Gokhale PC,et al. Comparative in vivo studies with paclitaxel and liposome encapsulated paclitaxel [J]. Int J Oncol,1998,12 (5):1035-1040. |